Status:
COMPLETED
Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID-19
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Covid-19
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Patients with Covid-19 (Coronavirus disease 19) may experience multiple neurological symptoms . 18F-FDG PET-CT ( Positons EmissionTomography coupled with a Computer Tomography with flurodesoxyglucose...
Detailed Description
Patients with Covid-19 may experience multiple neurological symptoms including confusion and headaches (non-specific neurological symptoms), while others develop specific neurological manifestations, ...
Eligibility Criteria
Inclusion
- Patients aged between 18 and 65 years
- Patient included in the Neurocog-Covid study (i.e. presenting a cognitive disorder that has been objectified on the neuropsychological assessment and having to undergo a cerebral MRI),
- Patient who has received full information about the organization of the research and has given written informed consent (or a third person, independent of the investigator and sponsor, in the case of literacy disability),
- Patient affiliated to or beneficiary of a social security plan
Exclusion
- Women of childbearing age who do not have effective contraception.
- Pregnant woman or nursing mother.
- Persons referred to in Articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health Code.
- Persons deprived of liberty by a judicial or administrative decision, persons undergoing psychiatric care pursuant to articles L. 3212-1 and L. 3213-1
- Contraindication to perform 18F-FDG PET-CT
- Patients with a history of pre-Covid-19 psychiatric or chronic illness
- Persons referred to in Articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health Code.
Key Trial Info
Start Date :
November 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 27 2023
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04764721
Start Date
November 17 2021
End Date
November 27 2023
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU NANCY Brabois, nuclear medicine department
Vandœuvre-lès-Nancy, France, 54511